Poor medication practices and inadequate system infrastructure—resulting in poor adherence, medication-related harms, and medication errors—too often results in patient harm. As many as 1 in 10 hospitalizations in OECD countries may be caused by a medication-related event and as many one in five inpatients experience medication-related harms during hospitalization. Together, costs from avoidable admissions due to medication-related events and added length of stay due to preventable hospital-acquired medication-related harms total over USD 54 billion in OECD countries. This report includes four components; it 1) assess the human impact and economic costs of medication safety events in OECD countries, 2) explores opportunities to improve prescribing practices 3) examines the state-of-the art in systems and policies for improving medication safety, and 4) provides recommendations for improving medication safety at the national level.
The economics of medication safety
Improving medication safety through collective, real-time learning
Working paper
OECD Health Working Papers
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
11 September 2024
-
14 August 2024
-
12 July 2024
Related publications
-
12 July 2024
-
19 January 2022